HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Terminal PEGylated DNA-Gold Nanoparticle Conjugates Offering High Resistance to Nuclease Degradation and Efficient Intracellular Delivery of DNA Binding Agents.

Abstract
Over the past 10 years, polyvalent DNA-gold nanoparticle (DNA-GNP) conjugate has been demonstrated as an efficient, universal nanocarrier for drug and gene delivery with high uptake by over 50 different types of primary and cancer cell lines. A barrier limiting its in vivo effectiveness is limited resistance to nuclease degradation and nonspecific interaction with blood serum contents. Herein we show that terminal PEGylation of the complementary DNA strand hybridized to a polyvalent DNA-GNP conjugate can eliminate nonspecific adsorption of serum proteins and greatly increases its resistance against DNase I-based degradation. The PEGylated DNA-GNP conjugate still retains a high cell uptake property, making it an attractive intracellular delivery nanocarrier for DNA binding reagents. We show that it can be used for successful intracellular delivery of doxorubicin, a widely used clinical cancer chemotherapeutic drug. Moreover, it can be used for efficient delivery of some cell-membrane-impermeable reagents such as propidium iodide (a DNA intercalating fluorescent dye currently limited to the use of staining dead cells only) and a diruthenium complex (a DNA groove binder), for successful staining of live cells.
AuthorsLei Song, Yuan Guo, Deborah Roebuck, Chun Chen, Min Yang, Zhongqiang Yang, Sreejesh Sreedharan, Caroline Glover, Jim A Thomas, Dongsheng Liu, Shengrong Guo, Rongjun Chen, Dejian Zhou
JournalACS applied materials & interfaces (ACS Appl Mater Interfaces) Vol. 7 Issue 33 Pg. 18707-16 (Aug 26 2015) ISSN: 1944-8252 [Electronic] United States
PMID26237203 (Publication Type: Journal Article)
Chemical References
  • Antibiotics, Antineoplastic
  • Coordination Complexes
  • Drug Carriers
  • Intercalating Agents
  • Propidium
  • Polyethylene Glycols
  • Gold
  • Ruthenium
  • Doxorubicin
  • DNA
  • Deoxyribonuclease I
Topics
  • Antibiotics, Antineoplastic (chemistry, toxicity)
  • Cell Survival (drug effects)
  • Coordination Complexes (chemistry, metabolism)
  • DNA (chemistry, metabolism)
  • Deoxyribonuclease I (chemistry, metabolism)
  • Doxorubicin (chemistry, toxicity)
  • Drug Carriers (chemistry)
  • Dynamic Light Scattering
  • Gold (chemistry)
  • HeLa Cells
  • Humans
  • Intercalating Agents (chemistry, metabolism)
  • Metal Nanoparticles (chemistry)
  • Microscopy, Confocal
  • Polyethylene Glycols (chemistry)
  • Propidium (chemistry, metabolism)
  • Ruthenium (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: